Literature DB >> 7973922

Acyclovir neurotoxicity: clinical experience and review of the literature.

J C Adair1, M Gold, R E Bond.   

Abstract

Acyclovir produces neurologic symptoms that resemble extension of viral infection into the central nervous system. We discuss our observations in the cases of two patients with acyclovir neurotoxicity and review the findings of all previous reports in the English language literature. Systemic disease, most commonly renal dysfunction, preceded all 30 reported cases of acyclovir neurotoxicity. The most common symptoms were mental status disorder and involuntary movements. Measurement of serum acyclovir levels substantiated the diagnosis in only a subset of patients. Although all patients recovered, hemodialysis hastened the rate of recovery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7973922     DOI: 10.1097/00007611-199412000-00006

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  14 in total

Review 1.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

2.  Case files of the Harvard medical toxicology fellowship: valacyclovir neurotoxicity and unintentional overdose.

Authors:  Colin Huguenel; Diana Felton; Rebecca Bruccoleri; Steven Salhanick
Journal:  J Med Toxicol       Date:  2015-03

3.  Acute renal injury induced by valacyclovir hydrochloride: A case report.

Authors:  Yanning Zhang; Yuxi Cong; Yan Teng
Journal:  Exp Ther Med       Date:  2016-11-15       Impact factor: 2.447

Review 4.  Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.

Authors:  W A Watson; N J Rhodes; I A Echenique; M P Angarone; M H Scheetz
Journal:  J Clin Pharm Ther       Date:  2017-03-29       Impact factor: 2.512

5.  Acute confusion in a 55-year-old man with end-stage renal disease.

Authors:  Sheliza Halani; Nisha Andany; Aaron Izenberg; Bourne Auguste
Journal:  CMAJ       Date:  2022-03-21       Impact factor: 16.859

6.  Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study.

Authors:  Ngan N Lam; Jamie L Fleet; Eric McArthur; Peter G Blake; Amit X Garg
Journal:  BMC Pharmacol Toxicol       Date:  2014-09-04       Impact factor: 2.483

Review 7.  A rare case report of acyclovir-induced immune thrombocytopenia with tongue hematomas as the first sign, and a literature review.

Authors:  Xiaowei Hong; Xiaoqian Wang; Zhiyong Wang
Journal:  BMC Pharmacol Toxicol       Date:  2017-03-07       Impact factor: 2.483

8.  Valacyclovir-induced Neurotoxicity in a Patient with a Preserved Renal Function.

Authors:  Takashi Yoshimura; Tatsuya Kawasaki; Ayumi Shirota; Masashi Saeki; Yuki Okada; Hiroshi Okada
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

9.  Synergistic Effect of ZnO Nanoparticles and Carbon Nanotube and Polymeric Film on Electrochemical Oxidation of Acyclovir.

Authors:  Ghasem Karim-Nezhad; Arezu Sarkary; Zeynab Khorablou; Parisa Seyed Dorraji
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

10.  Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

Authors:  Takuya Murakami; Tetsu Akimoto; Mari Okada; Erika Hishida; Taro Sugase; Atsushi Miki; Marina Kohara; Hiromichi Yoshizawa; Takahiro Masuda; Takahisa Kobayashi; Osamu Saito; Shigeaki Muto; Daisuke Nagata
Journal:  Drug Target Insights       Date:  2018-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.